NEW APPROACHES TO TREATMENT OF GASTROINTESTINAL CANCER
胃肠癌治疗新方法
基本信息
- 批准号:3093409
- 负责人:
- 金额:$ 80.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-04-01 至 1987-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This project is designed to bring together in a coordinated unit the
clinical research disciplines and related laboratories of the Mayo Clinic
for the purpose of improving both palliative and curative treatment of
human gastrointestinal cancer. The following specific areas will be
addressed: 1) Treatment of colorectal cancer. 2) Treatment of gastric and
pancreatic cancer. 3) Treatment of the less common gastrointestinal
carcinomas and 4) Gastrointestinal cancer pharmacology. Special emphasis
will be placed on the development and testing of innovative approaches to
regional disease and surgical adjuvant therapy with cure as a specific end
point. Of primary importance will be the integration directly into
clinical research programs of sophisticated laboratory endeavors in cancer
pharmacology. Particular strengths of this program include an unexcelled
depth of experience in gastrointestinal clinical cancer research; a devoted
clinical research team including all concerned disciplines; the
exceptionally large cancer patient population available at the Mayo Clinic
permitting meaningful studies to be performed in a timely fashion; the
uniquely large population of patients with newly diagnosed gastrointestinal
cancer permitting conduct of early disease studies; an extraordinarily
large population of patients with the less common gastrointestinal cancers;
strong relationships with community clinics in our region permitting a
continuum of management and expanded Phase III trials in the same data
base; and the well developed Mayo Cancer Center Statistical Unit which is
involved in all phases of our studies to insure sound protocol design,
consistent data quality, and informed and objective data analysis. We
believe these ingredients combined with our established productivity
provide maximum confidence that the work proposed will meet highest
scientific standards and will be conducted with unexcelled cost
effectiveness.
这个项目的目的是在一个协调单位汇集在一起
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES G. MOERTEL其他文献
CHARLES G. MOERTEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES G. MOERTEL', 18)}}的其他基金
NEW APPROACHES TO TREATMENT OF GASTROINTESTINAL CANCER
胃肠癌治疗新方法
- 批准号:
3093411 - 财政年份:1984
- 资助金额:
$ 80.11万 - 项目类别:
NEW APPROACHES TO TREATMENT OF GASTROINTESTINAL CANCER
胃肠癌治疗新方法
- 批准号:
3093407 - 财政年份:1984
- 资助金额:
$ 80.11万 - 项目类别:
NEW APPROACHES TO TREATMENT OF GASTROINTESTINAL CANCER
胃肠癌治疗新方法
- 批准号:
3093412 - 财政年份:1984
- 资助金额:
$ 80.11万 - 项目类别:
NEW APPROACHES TO TREATMENT OF GASTROINTESTINAL CANCER
胃肠癌治疗新方法
- 批准号:
3093408 - 财政年份:1984
- 资助金额:
$ 80.11万 - 项目类别:
NEW APPROACHES TO TREATMENT OF GASTROINTESTINAL CANCER
胃肠癌治疗新方法
- 批准号:
3093410 - 财政年份:1984
- 资助金额:
$ 80.11万 - 项目类别:
NEW APPROACHES TO TREATMENT BY GASTROINTESTINAL CANCER
胃肠癌治疗新方法
- 批准号:
3093403 - 财政年份:1984
- 资助金额:
$ 80.11万 - 项目类别:
NEW APPROACHES TO TREATMENT OF GASTROINTESTINAL CANCER
胃肠癌治疗新方法
- 批准号:
3093406 - 财政年份:1984
- 资助金额:
$ 80.11万 - 项目类别:
相似海外基金
Novel effective combination chemotherapy using epigenetic modifiers for targeting solid tumors
使用表观遗传修饰剂靶向实体瘤的新型有效联合化疗
- 批准号:
21K06699 - 财政年份:2021
- 资助金额:
$ 80.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of combination chemotherapy using NF-kappaB as molecular target for oral squamous cell carcinoma
以NF-κB为分子靶标的口腔鳞状细胞癌联合化疗的开发
- 批准号:
17K17258 - 财政年份:2017
- 资助金额:
$ 80.11万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Improving combination chemotherapy of tuberculosis: a computational approach
改善结核病联合化疗:一种计算方法
- 批准号:
9977085 - 财政年份:2016
- 资助金额:
$ 80.11万 - 项目类别:
The establishment of individualized medicine based on the pharmacological biomarkers in bladder cancer patients treated with gemcitabine-containing combination chemotherapy.
基于药理学生物标志物的膀胱癌患者接受含吉西他滨联合化疗的个体化治疗的建立。
- 批准号:
16K11027 - 财政年份:2016
- 资助金额:
$ 80.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving combination chemotherapy of tuberculosis: a computational approach
改善结核病联合化疗:一种计算方法
- 批准号:
9294943 - 财政年份:2016
- 资助金额:
$ 80.11万 - 项目类别:
Improving combination chemotherapy of tuberculosis: a computational approach
改善结核病联合化疗:一种计算方法
- 批准号:
9157047 - 财政年份:2016
- 资助金额:
$ 80.11万 - 项目类别:
Understanding the mechanisms of drug-drug synergy in combination chemotherapy
了解联合化疗中药物协同作用的机制
- 批准号:
nhmrc : GNT1072965 - 财政年份:2015
- 资助金额:
$ 80.11万 - 项目类别:
Early Career Fellowships
Development of combination chemotherapy using NF-kappaB as molecular target for oral cancer
以 NF-κB 作为口腔癌分子靶点的联合化疗的开发
- 批准号:
26861724 - 财政年份:2014
- 资助金额:
$ 80.11万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Mechanisms of dUTPase downregulation by oxaliplatin and its applications to combination chemotherapy
奥沙利铂下调dUTPase的机制及其在联合化疗中的应用
- 批准号:
24701028 - 财政年份:2012
- 资助金额:
$ 80.11万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy
用于时空控制联合化疗的靶向纳米颗粒
- 批准号:
7983673 - 财政年份:2010
- 资助金额:
$ 80.11万 - 项目类别:














{{item.name}}会员




